Summary
- Current Price
- As of today, EDIT price is $3.57, up +15.91% on
- Current Price All-Time High
- EDIT price is currently -96.06% below its historical high of $90.58 set on an earlier date
- Market Cap
- EDIT current market cap is $350M, up +153.05% over the past 365 days
- PE Ratio
- EDIT PE ratio is unknown
- Revenue
- EDIT current annual revenue is $40.52M, up +25.39% year-over-year
- Next Earnings
- The next earnings release for EDIT is on
Profile
| Metric | Value |
|---|---|
| Full Name | Editas Medicine, Inc. |
| Ticker | NASDAQ: EDIT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | editasmedicine.com |
| Employees | 246 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $3.57 | ||
| Price, 1D Change | +15.91% | |
| $350M | ||
| - | ||
| - | ||
| 2.57 | ||
| $41M | ||
| Revenue, 1Y Change | +25.39% | |
| -$1.80 | ||
| EPS, 1Y Change | +37.36% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.80 | ||
| EPS Estimate | N/A | -$0.99 |
| EPS Est. Change | N/A | +45.12% |
| $40.52M | ||
| Revenue Estimate | N/A | $14.14M |
| Revenue Est. Change | N/A | -65.10% |
| $3.57 | ||
| Price Target | - | $5.00 |
| Price Tgt. Change | - | +40.06% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.65 | -$2.88 | -8.62% | |
| -$1.94 | -$1.80 | +6.98% | |
| -$0.99 | N/A | +45.12% | |
| -$0.91 | N/A | +49.77% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $41.15M | $32.31M | -21.48% | |
| $23.96M | $40.52M | +69.09% | |
| $14.14M | N/A | -65.10% | |
| $14.00M | N/A | -65.44% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +116.36% | ||
| -60.77% | ||
| +153.05% | ||
| -44.33% | ||
| +25.39% | ||
| +105.56% | ||
| +37.36% | ||
| +43.82% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $3.57 | ||
| $2.66 | ||
| SMA 200 vs Price | -25.57% | |
| $2.84 | ||
| SMA 50 vs Price | -20.32% | |
| 2.57 | ||
| $0.31 | ||
| 67.36 | ||
| 115.65% | ||
| 94.14% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $40.52M | ||
| -$1.80 | ||
| $35.24M | ||
| 86.98% | ||
| -$99.34M | ||
| -245.15% | ||
| -$160.06M | ||
| -395.01% | ||
| -$94.06M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 2.81 | ||
| 3.54 | ||
| 3.54 | ||
| - | ||
| 2 | ||
| -11.69 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 9.03 | ||
| 79.30 | ||
| -3.50 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $27.29M | ||
| $146.65M | ||
| $186.53M | ||
| $163.90M | ||
| $159.25M | ||
| $46.25M | ||
| $76.71M | ||
| $11.03M | ||
| $2.61M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $200.58M | ||
| $134.58M | ||
| $5.28M | ||
| $49.90M | ||
| $5.28M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$165.24M | ||
| $138.67M | ||
| $40.47M | ||
| $607.00K | ||
| -$165.85M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Chardan Capital | → | |
| Jones Trading | → | |
| Chardan Capital | → | |
| HC Wainwright & Co. | → | |
| Wells Fargo | → | |
| HC Wainwright & Co. | → | |
| Baird | → | |
| Baird | → | |
| HC Wainwright & Co. | ||
| JP Morgan | → |
Analyst sentiment
Institutional ownership
Screeners with EDIT
FAQ
What is the ticker symbol for Editas Medicine, Inc.?
The ticker symbol for Editas Medicine, Inc. is NASDAQ:EDIT
Does Editas Medicine, Inc. pay dividends?
No, Editas Medicine, Inc. does not pay dividends
What sector is Editas Medicine, Inc. in?
Editas Medicine, Inc. is in the Healthcare sector
What industry is Editas Medicine, Inc. in?
Editas Medicine, Inc. is in the Biotechnology industry
What country is Editas Medicine, Inc. based in?
Editas Medicine, Inc. is headquartered in United States
When did Editas Medicine, Inc. go public?
Editas Medicine, Inc. initial public offering (IPO) was on February 3, 2016
Is Editas Medicine, Inc. in the S&P 500?
No, Editas Medicine, Inc. is not included in the S&P 500 index
Is Editas Medicine, Inc. in the NASDAQ 100?
No, Editas Medicine, Inc. is not included in the NASDAQ 100 index
Is Editas Medicine, Inc. in the Dow Jones?
No, Editas Medicine, Inc. is not included in the Dow Jones index
When was Editas Medicine, Inc. last earnings report?
Editas Medicine, Inc.'s most recent earnings report was on May 5, 2026
When does Editas Medicine, Inc. report earnings?
The next expected earnings date for Editas Medicine, Inc. is August 11, 2026
Data Sources & References
- EDIT Official Website www.editasmedicine.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1650664/000165066426000017/0001650664-26-000017-index.htm
- EDIT Profile on Yahoo Finance finance.yahoo.com/quote/EDIT
- EDIT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/edit